Semax
An Uplifting Peptide for Focus and Mental Clarity
Semax is a small peptide built from a fragment of a natural human hormone, redesigned so it feeds the nervous system without touching the hormone system. In our experience it lifts focus, mental clarity, and that locked-in feeling, which made it a favorite here before regulation took it off the menu in 2023. That restriction was lifted in 2026.
It is the uplifting half of a famous Russian pair: Semax brightens and sharpens, and its chemical cousin Selank calms and steadies. As with Selank, we will be straight about the evidence: Semax is a clinically used medicine in Russia with decades of history, while the Western-style trial record is thin.
.svg)
What we've seen in practice
Dr. Koniver likes Semax, and says so plainly: it seems to be energizing for the nervous system, and it helps people with focus, mental clarity, and just feeling locked in - a very positive experience for people. The biology matches what we see. Semax raises BDNF, a growth factor that helps brain circuits adapt, and in his words it allows the nervous system to communicate more efficiently.
We used it two ways. As a nasal spray it is a quick hit to the nervous system, in and out, which meant people could use it right before the moments that mattered: before work, before a workout, before anything that required them to get in, tune in, and lock in. As an injection it gave a steadier background effect. A detail worth knowing: responses differ. Some people found it too energizing late in the day, while others found it actually helped their sleep.
Our history with it started in recovery. We first reached for Semax after hard events for the nervous system, strokes and traumatic brain injuries among them, where Dr. Koniver observed that it seemed to help people find words faster and communicate more clearly. From there we extended it to healthy people who simply wanted their nervous system working better. Through all of it, his safety verdict was unambiguous: a great peptide, very safe, and we did not see issues with it.
Semax at a glance
A seven-amino-acid peptide (Met-Glu-His-Phe-Pro-Gly-Pro): a working fragment of the hormone ACTH with a stabilizing Pro-Gly-Pro tail, active in the brain without stimulating the hormone axis [6]
.svg)
Focus, mental clarity, and cognitive support; nervous-system recovery support; in Russia, a clinically used neurological medicine
.svg)
Real but mostly Russian: decades of clinical use and approval there, strong animal and mechanism research internationally, no large Western trials [1,2,3]
.svg)
As a nasal spray for a quick, short-lived effect, or by injection for a steadier one
.svg)
Met-Glu-His-Phe-Pro-Gly-Pro, formula C37H51N9O10S, about 813.9 g/mol [6]
Not FDA-approved; removed from the restricted compounding list in April 2026 and recommended by the FDA's advisory committee in July 2026; a clinically used medicine in Russia; not listed by WADA
A former favorite for focus and clarity, pulled from supply in 2023 and now cleared to return. See what we have seen in practice above
Solid beads = the working ACTH fragment (positions 4-7 of the hormone). Dashed beads = the Pro-Gly-Pro stability tail - the same tail Selank uses. The result keeps the fragment's brain effects and drops the adrenal stimulation of the parent hormone.
Where Semax comes from
Semax comes from the same Moscow laboratory that produced Selank: the Institute of Molecular Genetics of the Russian Academy of Sciences. The design problem was elegant. ACTH, a pituitary hormone, was known to have effects on attention and learning that had nothing to do with its day job of stimulating the adrenal glands. Researchers isolated the short piece responsible for the brain effects, then stabilized it with a Pro-Gly-Pro tail so it would survive long enough to work. The result, Semax, behaves like a nervous-system signal with the hormone half deleted.
In Russia it moved into clinical use decades ago and remains a medicine there, historically given as nasal drops, with stroke care among its established uses. Together with Selank it forms a deliberate pair from the same tradition: one peptide to lift and sharpen the nervous system, one to calm and settle it. We have used them exactly that way.
Semax
Selank
How it works
Three mechanisms carry most of what is known about Semax.
Animal studies show Semax increases BDNF, the growth factor that supports learning, adaptability, and the health of brain circuits. This is the mechanism Dr. Koniver points to first. [1]
As an ACTH fragment, Semax works on melanocortin signaling in the brain, the parent hormone's cognitive channel, while leaving the adrenal, steroid-producing side essentially alone. [6]
.svg)
Genome-wide studies in rat stroke models show Semax modulating large sets of immune- and blood-vessel-related genes, damping inflammation and cell-death signals while supporting repair pathways. [2,3]
The same evidence shape as Selank: real, useful, and geographically narrow.
What the research shows, and what it hasn't yet shown
The honest shape of the evidence is the same as Selank's: real, but concentrated in Russia.
On the clinical side, Semax has decades of use in Russia, where it is an approved neurological medicine with stroke care among its established applications. That is meaningful real-world history, and it is also not the same thing as large, independent, Western randomized trials, which have not been done. On the research side, the internationally indexed literature is strong but mostly preclinical: BDNF induction in living brains, and detailed genome-wide work in stroke models showing recovery-directed gene shifts. A smaller human literature exists, including brain-imaging work on how Semax and Selank affect brain networks.
One correction matters here. The reference page for this peptide lists three items under published human studies, and none of them is a human study: two are rat experiments and one is a theoretical paper about possible future uses. Its own limitations section admits the evidence is predominantly preclinical. We think the honest framing is better than the inflated one: the human layer for Semax is Russian clinical practice, not Western trials, and the strongest published science is mechanistic.
BDNF and brain-circuit support
Animal studies in living brains
Semax raises BDNF across brain regions
Well demonstrated preclinically [1]
Recovery after brain injury
Rat stroke models, genome-wide analyses; Russian clinical use
Gene programs shift toward repair; established Russian practice
Strong preclinical plus Russian clinical history [2,3]
Focus and cognition in healthy people
Human brain-imaging work; extensive practice experience
Network-level brain effects; consistent reported clarity
Early human research plus observation [4]
Large Western trials
None
Not independently confirmed at scale
A genuine gap
How strong is the evidence
Real Russian clinical history and strong mechanism science; the gap is large Western trials. Mirror of the Selank map.
Our experience matches the published picture. Dr. Koniver's verdict from years of use was that Semax was a great peptide, very safe, with no issues seen in our patients, none whatsoever. The literature adds only mild, transient effects: occasional nasal irritation from sprays, a rare mild headache, and in some sensitive people a feeling of being overstimulated, which settles with a lighter approach. It is not a stimulant and shows no dependence pattern.
The honest limits are familiar: the deep human safety record is Russian and mostly short-term, so long-term Western data is thin. We avoid it in pregnancy and breastfeeding for lack of data, and as a compounded product, the quality of the pharmacy matters. Physician supervision is the standing rule for everything we describe.
Regulatory status
Regulatory information current as of 13 August 2026. This is a summary, not legal or medical advice, and status can change.
Placed on restricted Category 2 - left the regulated compounding supply
Withdrawn from Category 2 - standard compounding rules apply again
Advisory committee recommends Semax advisory; final rulemaking pending
Russia
An approved, clinically used neurological medicine with decades of history.
United States
RESTRICTION LIFTED
Not FDA-approved. Pulled onto Category 2 in the fall 2023 review; withdrawn from that list on 22 April 2026; recommended by the FDA's Pharmacy Compounding Advisory Committee on 23-24 July 2026 (advisory). Verify current status.
Sport (WADA)
NOT LISTED
Not on the WADA Prohibited List. Anti-doping rules change, so competing athletes should confirm current status with their governing body.
Everywhere else
Generally a research compound outside Russia; products sold outside licensed channels carry the quality risks described in the safety section.
Regulatory information current as of 13 August 2026. Verify status at publication.
Common questions
A small peptide built from a working fragment of the hormone ACTH, stabilized so it lasts. It supports focus, mental clarity, and nervous-system function without acting on the hormone system, and it comes from the same Russian research family as Selank.
They are chemical cousins designed as opposites. Semax lifts and sharpens; Selank calms and steadies. Dr. Koniver combined them for what he calls a clean, calm focus, and they anchor the focus combination we have used alongside BPC-157 and MOTS-c.
Neither. Semax is not a stimulant, and nothing here replaces a prescription conversation with a physician. Some patients who prefer to avoid stimulants have liked the gentler, non-jittery focus of the Semax-Selank combination; that is a preference we have observed, not a medical equivalence.
The federal restriction that removed it from compounding in 2023 was withdrawn in April 2026, and the FDA's advisory committee recommended it for the approved compounding list in July 2026. The regulatory section above has the specifics; a licensed physician can speak to current availability.
It is not listed on the WADA Prohibited List. Competing athletes should still verify current status with their governing body, since lists change.
Related in this directory
References
- Dolotov OV, Seredenina TS, Levitskaya NG, et al. The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo. Dokl Biol Sci. 2003;391:292-295. PMID 14556513.
- Medvedeva EV, Dmitrieva VG, Povarova OV, et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014;15:228. PMID 24661604.
- Sudarkina OY, Filippenkov IB, Stavchansky VV, et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. Int J Mol Sci. 2021;22(12):6179. PMID 34201112.
- Panikratova YR, Lebedeva IS, Sokolov OY, et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. 2020;490(1):9-11. PMID 32342318.
- Kost NV, Sokolov OY, Gabaeva MV, et al. Semax and Selank inhibit the enkephalin-degrading enzymes from human serum. Bioorg Khim. 2001;27(3):180-183. PMID 11443939.
- Molecular data: Semax (Met-Glu-His-Phe-Pro-Gly-Pro), PubChem CID 9811102, formula C37H51N9O10S, molecular weight ~813.9 g/mol.
Medical disclaimer: This page is for informational and educational purposes and does not constitute medical advice, diagnosis, or treatment. The FDA has not approved Semax for any use in the United States; its clinical use is in Russia, and its broader human evidence base is limited and largely Russian. Statements describing how Dr. Koniver and the Koniver Wellness team used Semax reflect clinical experience and judgment, which is not the same as controlled clinical evidence. Nothing here is a substitute for consultation with a qualified healthcare provider. Peptide therapy at Koniver Wellness is provided under physician supervision after appropriate screening, and the availability of any given peptide depends on its regulatory and supply status.
INTERESTED IN PEPTIDES?
START WITH THE RIGHT QUESTIONS.
Understand what peptides can and cannot do, what the evidence actually says, and whether physician-guided peptide therapy makes sense for you.